Funding Opportunities and Announcements

Request for Information (RFI): Adolescent Medicine Trials Network for HIV/AIDS Interventions. Issued to the public by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Comments requested about the ATN to inform the adolescent HIV research agenda. Submission deadline is October 30. Details and how to respond are here.

 

Office of Strategic Coordination (Common Fund):

Also see the High Risk, High Reward Research Program from The Common Fund, National Institutes of Health Office of Strategic Coordination.

 

Four New Funding Opportunities, Rapid Acceleration of Diagnostics (RADX) Related to COVID-19 Testing

 

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

 

Minority HIV Research Initiative (MARI) to Support Epidemiologic and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers

 

NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) Posted August 17, 2020

 

Advancing HIV/AIDS Research within the Mission of the NIDCD (two opportunities): 

R21 Clinical Trial Optional

R01 Clinical Trial Optional

 

State/Tribal/Territorial Partnership Initiative to Document and Sustain Disparity-Reducing Interventions

 

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

 

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

 

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities

 

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

 

Reducing Stigma Related to Drug Use in Human Service Settings (R21 Clinical Trial Optional)

 

Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)

 

NIMHD William G. Coleman, Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award - applications due August 31, 2020.

 

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities

 

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

 

NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)

 

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

 

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

 

Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional)

 

Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions 

 

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

 

HIV/AIDS High Priority Drug Abuse Research 

 

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults 

 

Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions 

 

Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities 

 

Advancing Exceptional Research on HIV/AIDS & Substance Abuse 

 

Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation 

 

Promoting NICHD Areas of Research for HIV/AIDS in Maternal/Child Health 

 

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

 

Centers for AIDS Research (P30 Clinical Trial Not Allowed) 

 

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)